| |
| |
|
| Insider
Information: |
Countouriotis Athena |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
210,157 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,171,294 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
210,157 |
|
|
| Total
Value |
$3,171,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
1
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
-1.0
|
| Percentage
Gain/Loss : |
 66.8%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
SVP and Chief Medical ... |
2017-02-03 |
39,077 |
2015-12-31 |
0 |
Premium* |
|
|
Adverum Biotechnologies, Inc |
ADVM |
SVP, Chief Medical Off... |
2017-06-19 |
150,000 |
2017-06-19 |
0 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
President & CEO, Direc... |
2022-08-17 |
0 |
2019-09-10 |
0 |
Premium* |
|
|
Passage Bio, Inc. |
PASG |
Director |
2020-03-24 |
18,900 |
2020-03-03 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-12-27 |
2,180 |
2023-12-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
